MedTrace Logo

Intra-procedural 360-degree Display for Performing Percutaneous Liver Tumor Ablation

NCT03500757 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11

Last updated 2025-07-08

No results posted yet for this study

Summary

Medical images used to guide treatment of tumor(s) are presently displayed on flat-panel monitors (like screens used with computers). This protocol will evaluate, using a new headset to view the images in true 3D ("360 degrees"), while using standard flat panel monitors as usual (in accordance with standard of care). The headset is combined with a mini-global positioning system (GPS)-like system to help navigate to treat tumor(s). This evaluation is to show that the headset has potential to provide guidance and navigation information that can improve the treatment of tumor(s) with heat.

Conditions

  • Percutaneous Tumor Ablation

Interventions

DEVICE

HoloLens

use the HoloLens to evaluate new 3D holographic guidance and navigation for percutaneous ablation of solid tumors

Sponsors & Collaborators

  • Case Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Charles Martin III, MD · Cleveland Clinic, Case Comprehensive Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-29
Primary Completion
2020-08-17
Completion
2022-05-16
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03500757 on ClinicalTrials.gov